2 completed, 1 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
Follow K-877 compound: new trials by email Literature Review of K-877 compound trials Research Report on K-877 compound
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) K-877, Placebo - Type2 Diabetes, Dyslipidemia | Phase 3 | Terminated | Kowa Research Institute, Inc. | 10544 | 2017-03-23 | 2025-09-25 |
| Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function K-877, Fenofibrate, Placebo (for K-877) - Severe Hypertriglyceridemia | Phase 3 | Completed | Kowa Research Institute, Inc. | 551 | 2016-11-28 | 2022-11-30 |
| Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment K-877, Fenofibrate, Placebo (for K-877) - Severe Hypertriglyceridemia | Phase 3 | Completed | Kowa Research Institute, Inc. | 471 | 2016-11-26 | 2022-10-28 |
Hypertriglyceridemia (2) · Dyslipidemias (1)
Kowa Research Institute, Inc. (3)
Bulgaria (3) · Czechia (3) · Hungary (3) · Poland (3) · Russia (3) · Ukraine (3) · United States (3) · Belarus (2) · Georgia (2) · Argentina (1) · Brazil (1) · Canada (1) · Colombia (1) · Denmark (1) · France (1)
Aruna Pradhan, MD (1) · Paul Ridker, MD (1)